Dynavax Technologies
DVAX
#5493
Rank
NZ$2.22 B
Marketcap
NZ$18.98
Share price
-0.09%
Change (1 day)
-13.77%
Change (1 year)

Dynavax Technologies (DVAX) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$0.49 Billion

According to Dynavax Technologies 's latest financial reports the company's total debt is NZ$0.49 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Dynavax Technologies - Total debt on balance sheet (from 2009 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$0.45 B11.04%
2023-12-31NZ$0.40 B-0.03%
2022-12-31NZ$0.40 B7.84%
2021-12-31NZ$0.37 B24.81%
2020-12-31NZ$0.30 B-6.06%
2019-12-31NZ$0.32 B113.71%
2018-12-31NZ$0.15 B
2014-12-31NZ$12.2 M
2012-12-31N/A-100%
2011-12-31NZ$16.41 M7.48%
2010-12-31NZ$15.27 M-10.42%
2009-12-31NZ$17.04 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Agenus
AGEN
NZ$79.24 M-83.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$11.41 B 2,212.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$71.63 B 14,415.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$43.18 B 8,650.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$56.49 B 11,348.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
NZ$41.31 B 8,271.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
NZ$105.35 B 21,248.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$29.56 B 5,890.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
NZ$94.51 B 19,051.72%๐Ÿ‡บ๐Ÿ‡ธ USA